TY  - GEN
AU  - Wefer,Björn
AU  - Ehlken,Birgit
AU  - Bremer,Jörn
AU  - Burgdörfer,Harald
AU  - Domurath,Burkhard
AU  - Hampel,Christian
AU  - Kutzenberger,Johannes
AU  - Seif,Christoph
AU  - Sievert,Karl D
AU  - Berger,Karin
AU  - Pannek,Jürgen
TI  - Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany
SN  - 1433-8726
PY  - 2010///0824
KW  - Adult
KW  - Botulinum Toxins, Type A
KW  - economics
KW  - Chi-Square Distribution
KW  - Cohort Studies
KW  - Cost of Illness
KW  - Cost-Benefit Analysis
KW  - Cross-Sectional Studies
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Germany
KW  - Humans
KW  - Injections, Intramuscular
KW  - Male
KW  - Meningomyelocele
KW  - complications
KW  - Middle Aged
KW  - Multiple Sclerosis
KW  - Probability
KW  - Quality of Life
KW  - Retrospective Studies
KW  - Severity of Illness Index
KW  - Spinal Cord Injuries
KW  - Statistics, Nonparametric
KW  - Treatment Outcome
KW  - Urinary Bladder, Neurogenic
KW  - diagnosis
KW  - Urinary Bladder, Overactive
KW  - Urodynamics
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00345-009-0466-1
ER  -